Literature DB >> 6138641

Nalidixic acid for shigellosis.

J G McCormack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6138641     DOI： 10.1016/s0140-6736(83)91081-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.

Authors:  F Rogerie; D Ott; J Vandepitte; L Verbist; P Lemmens; I Habiyaremye
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

2.  High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada--an update.

Authors:  N Harnett
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

Review 3.  Use of quinolones in the treatment of gastrointestinal infections.

Authors:  H L DuPont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

4.  Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa.

Authors:  J A Frost; G A Willshaw; E A Barclay; B Rowe; P Lemmens; J Vandepitte
Journal:  J Hyg (Lond)       Date:  1985-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.